Sanofi-Dynavax deal receives US, German antitrust clearances
Sanofi and Dynavax Technologies have said the antitrust waiting period with the US antitrust authorities for their $2.2 billion deal expired on Jan. 27. The pharmaceutical companies also said they received...To view the full article, register now.
Already a subscriber? Click here to view full article